Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cy5 maleimide non sulfonated 5mg'

Search results for: 'cy5 maleimide non sulfonated 5mg'

Items 101-110 of 173

Page
per page
  1. AS 1892802
    B5773 AS 1892802
    Summary: ROCK inhibitor,potent and ATP-competitive
      Soluble in DMSO
  2. PHA-680632
    A4122 PHA-680632
    Target: Aurora Kinases|PLK|FGFR
    Summary: Aurora kinase inhibitor,novel and potent
      ≥50.2 mg/mL
  3. ELR510444
    B5870 ELR510444
    Summary: Novel microtubule disruptor
      insoluble in H2O; insoluble in EtOH; ≥11.9 mg/mL
  4. CP-466722
    A8625 CP-466722
    Target: ATM
    Summary: ATM inhibitor,potent and reversible
      ≥4.36 mg/mL
  5. AMG 925
    B3277 AMG 925
    Target: Cyclin-Dependent Kinases|FLT3
    Summary: FLT3/CDK4 inhibitor,potent and selective
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  6. Purvalanol B
    A8565 Purvalanol B
     1 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK1/CDK2/CDK4 inhibitor
      ≥21.65 mg/mL
  7. NSC23766 trihydrochloride
    A1952 NSC23766 trihydrochloride
    Summary: Selective inhibitor of Rac1-GEF interaction.
      ≥26.55 mg/mL
  8. RI-1
    A3764 RI-1
    Target: RAD51
    Summary: RAD51 inhibitor,cell-permeable
      insoluble in H2O; ≥18.1 mg/mL
  9. AZD7762
    A5919 AZD7762
    Target: Chk
    Summary: Checkpoint kinase inhibitor,ATP competitive
      insoluble in H2O; insoluble in EtOH; ≥18.1 mg/mL
  10. Cdk1/2 Inhibitor III
    C3679 Cdk1/2 Inhibitor III
    Summary: Cdk1/cyclin B and Cdk2/cyclin A inhibitor
      ≤10 mg/mL

Items 101-110 of 173

Page
per page
Shop By
Now Shopping by
  1. Category Cell Cycle/Checkpoint Remove This Item
Clear All
Shopping Options
Category
  1. ATM/ATR 4item
  2. Aurora Kinase 22item
  3. Cdc42 3item
  4. Cdc7 1 item
  5. Chk 10item
  6. c-Myc 3item
  7. CRM1 2item
  8. Cyclin-Dependent Kinases 52item
  9. E1 enzyme 1 item
  10. G-quadruplex 3item
  11. Haspin 1 item
  12. HMTase 1 item
  13. Kinesin 6item
  14. Ksp 3item
  15. Microtubule/Tubulin 18item
  16. Mps1 2item
  17. Mitotic 1 item
  18. RAD51 1 item
  19. ROCK 8item
  20. Rho 7item
  21. PAK1 4item
  22. PAK4 1 item
  23. PERK 3item
  24. PLK 15item
  25. Wee1 1 item
Specificity
  1. Selective 54item
Reversibility
  1. Reversible 5item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 22item
  2. PI3K 2item
  3. Aurora Kinases 15item
  4. mTOR 1 item
  5. FLT3 4item
  6. GSK-3 1 item
  7. PLK 9item
  8. Chk 7item
  9. PDGFR 1 item
  10. RET 1 item
  11. Bromodomain-containing proteins(BRDs) 1 item
  12. MEK 1 item
  13. FGFR 1 item
  14. Voltage-gated Sodium (NaV) Channels 1 item
  15. Src 3item
  16. Microtubules/Tubulins 3item
  17. ROCK 4item
  18. PAK 2item
  19. JAK 1 item
  20. DNA-PK 1 item
  21. Ksp 2item
  22. RAD51 1 item
  23. LRRK2 1 item
  24. ATM/ATR 3item
  25. G-quadruplexes 1 item
  26. Hck 1 item
  27. Ubiquitin-activating Enzyme E1 1 item
  28. Microtubule/Tubulin 3item
  29. VEGFR3/FLT4 1 item
  30. NTRK1/TRKA 1 item
  31. CSF-1R/c-Fms 1 item
  32. Hec1 1 item
  33. Lck 1 item
  34. FGR 1 item
  35. YES 1 item
  36. Fyn 1 item
  37. ARG 1 item
  38. ATM 1 item
Reported Experiments
  1. Animal Experiments 60item
  2. Cell Experiments 46item
Related Disease
  1. Acute Myeloid Leukemia 5item
  2. B-lymphoid Malignancies 1 item
  3. Breast Cancer 13item
  4. Cancer 55item
  5. Cervical Cancer 1 item
  6. Chronic Lymphocytic Leukemia 2item
  7. Colon Cancer 8item
  8. Colorectal Cancer 4item
  9. Glioblastoma 1 item
  10. Leukemia 1 item
  11. Liver Cancer 1 item
  12. Lung Cancer 3item
  13. Lymphoma 4item
  14. Mantle Cell Lymphoma 1 item
  15. Melanoma 2item
  16. Multiple Myeloma 1 item
  17. Neuroblastoma 1 item
  18. Non-small Cell Lung Carcinoma 1 item
  19. Ovarian Cancer 8item
  20. Pancreatic Cancer 6item
  21. Prostate Cancer 4item